Volume : 12, Issue : 01, January – 2025

Title:

CELLULITIS: A COMPREHENSIVE STUDY OF THE MEDICAL MANAGEMENT OF CELLULITIS

‬

Authors :

Vaishnavi Gawande, vaishnavi surve, Vinayak katekar, Swati Deshmukh

Abstract :

Cellulitis is a bacterial infection of the skin, presenting with poorly demarcated erythema, edema, warmth, and ten demess. Although common, it often can be a diagnostic and therapeutic challenge. In this review, the pathophysiology, micro- biology, clinical presentation, and risk factors of cellulitis are dis cussed. Cellulitis can occur in any part of the body especially in legs and face. The bacteria most commonly involved are streptococci and Staphylococcus aureus. When left untreated it affects the lymphatic vessels and reaches the circulation causing serious conditions. The borders of the area of redness are generally not sharp and the skin may be swollen. Lymphatic vessels may occasionally be involved. This review deals about the infection spread, symptoms, investigations, and treatment in cellulitis. The approach to diagnosis is reviewed and the importance of differeritiating cellulitis from clinical mimics of cellulitis is highlighted. An approach to empirical treatment is presented, with re- cent recommendations from the literature. Cellulitis is an infection of the deep dermis and subcutaneous tissue, presenting with expanding erythema, warmth, tenderness, and swelling. Cellulitis is a common global health burden, with more than 650 000 admissions per year in the United States alone.
Keywords: Infection, Management, Cellulitis

Cite This Article:

Please cite this article in press Vaishnavi Gawande et al., Cellulitis: A Comprehensive Study Of The Medical Management Of Cellulitis.,Indo Am. J. P. Sci, 2025; 12 (01).

Number of Downloads : 10

References:

1) Cox NH et al., Management and morbidity of cellulitis of the leg. J R Soc Med 1998; 91:634-7.
2) Jorup-Rönström C et al., Recurrent erysipelas: predisposing factors and cost of prophylaxis. Infection 1987; 15:105-6.
3) Keeley VL. Lymphedemas and cellulitis: chicken or egg? Br J Dermatol 2008;158:1175-6.
4) Aboltins CA, et al; Oral versus parenteral antimicrobials for the treatment of cellulitis: a randomized non-inferiority trial. J Antimicrob Chemother. 2015 Feb;70 (2):581-6. Doi: 10.1093/jac/dku397. Epub 2014 Oct 21.
5) Paul M. Newell et al.,”Value of Needle Aspiration in Bacteriologic Diagnosis of Cellulitis in Adults “, Journal of Clinical Microbiology, Vol 26. No.3; p 401-404.
6) Miller LG et al; Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015 Mar 19; 372 (12) : 1093-103. Doi: 10.1056/NEJMoa1403789.
7) Consensus Document on the Management of Cellulitis in Lymphoedema; British Lymphology Society (2013)
8) Chan YL et al., C-reactive protein as an indicator of bacterial infection of adult patients in the emergency department. Chang GungMed J 2002; 25:437-45
9) Clinical Resource Efficiency Support Team (2005) Guidelines on the management of cellulitis in adults. Crest, Belfast. http://www.acutemed.co.uk/docs/Cellulitis % 20guidelines, % 20 CREST , % 2005 .pdf.
10) Dr Henry knipe et al.”Cellulitis”, http://radiopaedia.org/articles/cellulitis
11) Woo PCY, Lum PNL, Wong SSY, Cheng VC, Yuen KY. Cellulitis complicating lymph- oedema. Eur J Clin Microbiol Infect Dis 2000;19:294-7.
12) Parada JP, Maslow JN. Clinical syn- dromes associated with adult pneumococcal cellulitis. Scand J Infect Dis 2000;32:133-6.
13) Porras MC, Martínez VC, Ruiz IM, et al. Acute cellulitis: an unusual manifestation of meningococcal disease. Scand J Infect Dis 2001;33:56-9.
14) Chuang Y-C, Yuan C-Y, Liu C-Y, Lan CK, Huang AH. Vibrio vulnificus infection in Tai- wan: report of 28 cases and review of clinical manifestations and treatment. Clinical Infect Dis 1992;15 : 271-6
15) 1992;15:271-6. 13. Fernandez JM, Serrano M, De Arriba JJ, Sanchez MV, Escribano E, Ferreras P. Bacte- remic cellulitis caused by non-01, non-0139 Vibrio cholerae: report of a case in a patient with hemochromatosis. Diagn Microbiol Infect Dis 2000;37:77-80.
16) 14. Gach JE, Charles-Holmes R, Ghose A. E. coli cellulitis. Clin Exp Dermatol 2002;27: 523-5.
17) Barzilai A, Choen HA. Isolation of group A streptococci from children with perianal cellulitis and from their siblings. Pediatr Infect Dis J 1998;17:358-60.
18) Binswanger IA, Kral AH, Blumenthal RN, DJ, Edlin BR. High prevalence of abscesses and cellulitis among community- recruited injection drug users in San Fran- cisco. Clin Infect Dis 2000;30:579-81.
19) Dancer SJ, McNair D, Finn P, Kolsto AB. Bacillus cereus cellulitis from contaminated heroin. J Med Microbiol 2002;51:278-81.
20) 4. Simon MS, Cody RL. Cellulitis after axil- lary lymph node dissection for carcinoma of the breast. Am J Med 1992;93:543-8.
21) 5. Mertz KR, Baddour LM, Bell JL, Gwin JL. Breast cellulitis following breast conserva- tion therapy: a novel complication of medi- cal progress. Clin Infect Dis 1998;26:481-6.
22) Gunderson CG. Cellulitis: definition, etiology, and clinical features. Am J Med. 2011;124(12):1113-22.
23) CREST (Clinical Resource Efficiency Support Team) Guidelines On The Management Of Cellulitis In Adults. CREST. 2005;1-31.
24) Kilburn SA et al. Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev. 2010;(6):CD004299.
25) Morris AD. Cellulitis and erysipelas. Clin Evid (Online). 2008;pii:1708.
26) Swartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004;350(9):904-12.
27) Hook EW 3rd. Acute cellulitis. Arch Dermatol. 1987;127:460-1.
28) Watt RW et al. Systemic Haemophilus influenzae and facial cellulitis in infants. Br Med J (Clin Res Ed). 1981;282(6261):399.
29) Charnock DR et al. Bruised cheek syndrome: Haemophilus influenzae, type B, cellulitis. Otolaryngol Head Neck Surg. 1990;103(5(Pt 1)):829-30.
30) Bouvet A. Cellulitis and necrotizing fasciitis: microbiology and pathogenesis. Ann Dermatol Venereol. 2001;128(3 Pt 2):382-9.
31) Roujeau JC. Necrotizing fasciitis. Clinical criteria and risk factors. Ann Dermatol Venereol. 2001;128(3 Pt 2):376- 81.